The Role of Macrolides and Doxycycline in Chronic Rhinosinusitis

Katherine A. Lees, Richard R. Orlandi, Gretchen Oakley, Jeremiah A. Alt

Research output: Contribution to journalReview articlepeer-review

Abstract

Antibiotic therapy has become an important adjunct in the management of recalcitrant chronic rhinosinusitis (CRS) because of some antibiotics’ immunomodulatory properties even at subtherapeutic antimicrobial levels. Macrolide antibiotics, such as clarithromycin and azithromycin, decrease production of proinflammatory cytokines, impair neutrophil recruitment, inhibit bacterial biofilm formation, and improve mucus quality. Doxycycline, a tetracycline antibiotic, inhibits the activity of matrix metalloproteinases in CRS with nasal polyposis. This article reviews the clinical applications for macrolide and doxycycline use in CRS, considerations for dosing and duration of treatment, and important side effects and drug interactions associated with these medications.

Original languageEnglish (US)
Pages (from-to)303-315
Number of pages13
JournalImmunology and Allergy Clinics of North America
Volume40
Issue number2
DOIs
StatePublished - May 2020
Externally publishedYes

Keywords

  • Chronic
  • Doxycycline
  • Immunomodulation
  • Macrolides
  • Polyps
  • Rhinosinusitis
  • Sinusitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'The Role of Macrolides and Doxycycline in Chronic Rhinosinusitis'. Together they form a unique fingerprint.

Cite this